BIOLOGICAL · Unmapped registry intervention
talactoferrin
Find medicine records ·
Find other trials using this name
Clinical trial
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
NCT01528137
Study summary
ClinicalTrials.govTalactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Recurrent Salivary Gland Cancerunresolved
Stage III Salivary Gland Cancerunresolved
Stage IV Non-small Cell Lung Cancerunresolved
Stage IVA Salivary Gland Cancerunresolved
Stage IVB Salivary Gland Cancerunresolved
Stage IVC Salivary Gland Cancerunresolved
Tongue Cancerverified · MONDO: tongue cancer
Interventions
talactoferrinBIOLOGICAL
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01528137 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.